We are live on ! Find out more
SVNT

SAVIENT PHARMACEUTICALS INC
SVNT

Delisted

SVNT was delisted on the 16th of October, 2013.

Back to rankings

47 hedge funds and large institutions have $14.1M invested in SAVIENT PHARMACEUTICALS INC in 2013 Q2 according to their latest regulatory filings, with 47 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

85% more call options, than puts

Call options by funds: $304K | Put options by funds: $164K

Holders
47
Holders Change
+47
Holders Change %
–
% of All Funds
1.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
47
Increased
–
Reduced
–
Closed
–
Calls
$304K
Puts
$164K
Net Calls
+$140K
Net Calls Change
+$140K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PAI
1
Palo Alto Investors
California
$5.46M +$6.79M +9,744,833 New
Franklin Resources
2
Franklin Resources
California
$2.05M +$2.56M +3,667,700 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.78M +$2.22M +3,180,778 New
BIT
4
BlackRock Institutional Trust
California
$1.25M +$1.56M +2,238,771 New
Wellington Management Group
5
Wellington Management Group
Massachusetts
$982K +$1.22M +1,753,890 New
PSAMP
6
P. Schoenfeld Asset Management (PSAM)
New York
$584K +$726K +1,042,436 New
Fidelity Investments
7
Fidelity Investments
Massachusetts
$195K +$243K +348,908 New
Millennium Management
8
Millennium Management
New York
$173K +$215K +308,226 New
Geode Capital Management
9
Geode Capital Management
Massachusetts
$173K +$215K +308,417 New
Morgan Stanley
10
Morgan Stanley
New York
$149K +$185K +265,475 New
BCM
11
Bridgeway Capital Management
Texas
$141K +$175K +251,900 New
Barclays
12
Barclays
United Kingdom
$110K +$137K +196,266 New
D.E. Shaw & Co
13
D.E. Shaw & Co
New York
$107K +$133K +190,359 New
Northern Trust
14
Northern Trust
Illinois
$100K +$125K +179,687 New
William Blair & Company
15
William Blair & Company
Illinois
$95K +$118K +170,000 New
Creative Planning
16
Creative Planning
Kansas
$73K +$91K +130,600 New
CD
17
Carl Domino
Florida
$70K +$86.6K +124,370 New
Bank of New York Mellon
18
Bank of New York Mellon
New York
$68K +$84K +120,548 New
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
$67K +$83.3K +119,569 New
Nomura Holdings
20
Nomura Holdings
Japan
$47K +$54.7K +78,500 New
Citadel Advisors
21
Citadel Advisors
Florida
$42K +$52.7K +75,598 New
Citigroup
22
Citigroup
New York
$39K +$49.6K +71,144 New
U
23
UBS
Switzerland
$36K +$45.4K +65,100 New
KCG
24
Knight Capital Group
$29K +$34.4K +49,313 New
Deutsche Bank
25
Deutsche Bank
Germany
$28K +$34.8K +50,000 New
1
2

SVNT Hedge Fund Activity: Q2 2013 in Review

47 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in SAVIENT PHARMACEUTICALS INC (SVNT) for Q2 2013, worth a combined $14.1M.

Buyers outnumbered sellers: 47 funds opened new SVNT positions and 0 closed out — a net gain of 47 holders — while 0 added to existing stakes and 0 trimmed.

  • 47 institutional investors held SAVIENT PHARMACEUTICALS INC (SVNT) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $14.1M of SAVIENT PHARMACEUTICALS INC stock for Q2 2013.
  • 47 funds opened new SAVIENT PHARMACEUTICALS INC positions in Q2 2013 and 0 closed out, a net change of +47 holders.

Based on aggregated 13F filings for Q2 2013.